Global Tuberculosis (TB) Diagnostics Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Tuberculosis (TB) Diagnostics market size was valued at US$ 2953 million in 2024 and is forecast to a readjusted size of USD 3977 million by 2031 with a CAGR of 4.4% during review period.
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term 'consumption' came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.
APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.
In terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.
This report is a detailed and comprehensive analysis for global Tuberculosis (TB) Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Tuberculosis (TB) Diagnostics market size and forecasts, in consumption value ($ Million), 2020-2031
Global Tuberculosis (TB) Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Tuberculosis (TB) Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Tuberculosis (TB) Diagnostics market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Tuberculosis (TB) Diagnostics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Tuberculosis (TB) Diagnostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, Hologic, Qiagen, BioMerieux, Hain Lifescience, Oxford Immunotec, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Tuberculosis (TB) Diagnostics market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Tuberculosis (TB) Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Tuberculosis (TB) Diagnostics, with revenue, gross margin, and global market share of Tuberculosis (TB) Diagnostics from 2020 to 2025.
Chapter 3, the Tuberculosis (TB) Diagnostics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Tuberculosis (TB) Diagnostics market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Tuberculosis (TB) Diagnostics.
Chapter 13, to describe Tuberculosis (TB) Diagnostics research findings and conclusion.
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term 'consumption' came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.
APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.
In terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.
This report is a detailed and comprehensive analysis for global Tuberculosis (TB) Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Tuberculosis (TB) Diagnostics market size and forecasts, in consumption value ($ Million), 2020-2031
Global Tuberculosis (TB) Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Tuberculosis (TB) Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Tuberculosis (TB) Diagnostics market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Tuberculosis (TB) Diagnostics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Tuberculosis (TB) Diagnostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, Hologic, Qiagen, BioMerieux, Hain Lifescience, Oxford Immunotec, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Tuberculosis (TB) Diagnostics market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Culture-Based Diagnostics
- Sputum Smear Microscopy
- Rapid Molecular Diagnostics
- Others
- Diagnostic Laboratories
- Hospitals
- Danaher
- Roche
- Thermo Fisher Scientific
- BD
- Abbott
- Hologic
- Qiagen
- BioMerieux
- Hain Lifescience
- Oxford Immunotec
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Tuberculosis (TB) Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Tuberculosis (TB) Diagnostics, with revenue, gross margin, and global market share of Tuberculosis (TB) Diagnostics from 2020 to 2025.
Chapter 3, the Tuberculosis (TB) Diagnostics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Tuberculosis (TB) Diagnostics market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Tuberculosis (TB) Diagnostics.
Chapter 13, to describe Tuberculosis (TB) Diagnostics research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Tuberculosis (TB) Diagnostics by Type
1.3.1 Overview: Global Tuberculosis (TB) Diagnostics Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Tuberculosis (TB) Diagnostics Consumption Value Market Share by Type in 2024
1.3.3 Culture-Based Diagnostics
1.3.4 Sputum Smear Microscopy
1.3.5 Rapid Molecular Diagnostics
1.3.6 Others
1.4 Global Tuberculosis (TB) Diagnostics Market by Application
1.4.1 Overview: Global Tuberculosis (TB) Diagnostics Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Diagnostic Laboratories
1.4.3 Hospitals
1.5 Global Tuberculosis (TB) Diagnostics Market Size & Forecast
1.6 Global Tuberculosis (TB) Diagnostics Market Size and Forecast by Region
1.6.1 Global Tuberculosis (TB) Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Tuberculosis (TB) Diagnostics Market Size by Region, (2020-2031)
1.6.3 North America Tuberculosis (TB) Diagnostics Market Size and Prospect (2020-2031)
1.6.4 Europe Tuberculosis (TB) Diagnostics Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size and Prospect (2020-2031)
1.6.6 South America Tuberculosis (TB) Diagnostics Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Danaher
2.1.1 Danaher Details
2.1.2 Danaher Major Business
2.1.3 Danaher Tuberculosis (TB) Diagnostics Product and Solutions
2.1.4 Danaher Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Danaher Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Tuberculosis (TB) Diagnostics Product and Solutions
2.2.4 Roche Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Roche Recent Developments and Future Plans
2.3 Thermo Fisher Scientific
2.3.1 Thermo Fisher Scientific Details
2.3.2 Thermo Fisher Scientific Major Business
2.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product and Solutions
2.3.4 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.4 BD
2.4.1 BD Details
2.4.2 BD Major Business
2.4.3 BD Tuberculosis (TB) Diagnostics Product and Solutions
2.4.4 BD Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 BD Recent Developments and Future Plans
2.5 Abbott
2.5.1 Abbott Details
2.5.2 Abbott Major Business
2.5.3 Abbott Tuberculosis (TB) Diagnostics Product and Solutions
2.5.4 Abbott Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Abbott Recent Developments and Future Plans
2.6 Hologic
2.6.1 Hologic Details
2.6.2 Hologic Major Business
2.6.3 Hologic Tuberculosis (TB) Diagnostics Product and Solutions
2.6.4 Hologic Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Hologic Recent Developments and Future Plans
2.7 Qiagen
2.7.1 Qiagen Details
2.7.2 Qiagen Major Business
2.7.3 Qiagen Tuberculosis (TB) Diagnostics Product and Solutions
2.7.4 Qiagen Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Qiagen Recent Developments and Future Plans
2.8 BioMerieux
2.8.1 BioMerieux Details
2.8.2 BioMerieux Major Business
2.8.3 BioMerieux Tuberculosis (TB) Diagnostics Product and Solutions
2.8.4 BioMerieux Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 BioMerieux Recent Developments and Future Plans
2.9 Hain Lifescience
2.9.1 Hain Lifescience Details
2.9.2 Hain Lifescience Major Business
2.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Product and Solutions
2.9.4 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Hain Lifescience Recent Developments and Future Plans
2.10 Oxford Immunotec
2.10.1 Oxford Immunotec Details
2.10.2 Oxford Immunotec Major Business
2.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Product and Solutions
2.10.4 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Oxford Immunotec Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Tuberculosis (TB) Diagnostics Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Tuberculosis (TB) Diagnostics by Company Revenue
3.2.2 Top 3 Tuberculosis (TB) Diagnostics Players Market Share in 2024
3.2.3 Top 6 Tuberculosis (TB) Diagnostics Players Market Share in 2024
3.3 Tuberculosis (TB) Diagnostics Market: Overall Company Footprint Analysis
3.3.1 Tuberculosis (TB) Diagnostics Market: Region Footprint
3.3.2 Tuberculosis (TB) Diagnostics Market: Company Product Type Footprint
3.3.3 Tuberculosis (TB) Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Tuberculosis (TB) Diagnostics Consumption Value and Market Share by Type (2020-2025)
4.2 Global Tuberculosis (TB) Diagnostics Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Tuberculosis (TB) Diagnostics Consumption Value Market Share by Application (2020-2025)
5.2 Global Tuberculosis (TB) Diagnostics Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Tuberculosis (TB) Diagnostics Consumption Value by Type (2020-2031)
6.2 North America Tuberculosis (TB) Diagnostics Market Size by Application (2020-2031)
6.3 North America Tuberculosis (TB) Diagnostics Market Size by Country
6.3.1 North America Tuberculosis (TB) Diagnostics Consumption Value by Country (2020-2031)
6.3.2 United States Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
6.3.3 Canada Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
6.3.4 Mexico Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Tuberculosis (TB) Diagnostics Consumption Value by Type (2020-2031)
7.2 Europe Tuberculosis (TB) Diagnostics Consumption Value by Application (2020-2031)
7.3 Europe Tuberculosis (TB) Diagnostics Market Size by Country
7.3.1 Europe Tuberculosis (TB) Diagnostics Consumption Value by Country (2020-2031)
7.3.2 Germany Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
7.3.3 France Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
7.3.5 Russia Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
7.3.6 Italy Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Region
8.3.1 Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Region (2020-2031)
8.3.2 China Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
8.3.3 Japan Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
8.3.4 South Korea Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
8.3.5 India Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
8.3.7 Australia Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Tuberculosis (TB) Diagnostics Consumption Value by Type (2020-2031)
9.2 South America Tuberculosis (TB) Diagnostics Consumption Value by Application (2020-2031)
9.3 South America Tuberculosis (TB) Diagnostics Market Size by Country
9.3.1 South America Tuberculosis (TB) Diagnostics Consumption Value by Country (2020-2031)
9.3.2 Brazil Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
9.3.3 Argentina Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country
10.3.1 Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Country (2020-2031)
10.3.2 Turkey Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
10.3.4 UAE Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Tuberculosis (TB) Diagnostics Market Drivers
11.2 Tuberculosis (TB) Diagnostics Market Restraints
11.3 Tuberculosis (TB) Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Tuberculosis (TB) Diagnostics Industry Chain
12.2 Tuberculosis (TB) Diagnostics Upstream Analysis
12.3 Tuberculosis (TB) Diagnostics Midstream Analysis
12.4 Tuberculosis (TB) Diagnostics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Tuberculosis (TB) Diagnostics by Type
1.3.1 Overview: Global Tuberculosis (TB) Diagnostics Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Tuberculosis (TB) Diagnostics Consumption Value Market Share by Type in 2024
1.3.3 Culture-Based Diagnostics
1.3.4 Sputum Smear Microscopy
1.3.5 Rapid Molecular Diagnostics
1.3.6 Others
1.4 Global Tuberculosis (TB) Diagnostics Market by Application
1.4.1 Overview: Global Tuberculosis (TB) Diagnostics Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Diagnostic Laboratories
1.4.3 Hospitals
1.5 Global Tuberculosis (TB) Diagnostics Market Size & Forecast
1.6 Global Tuberculosis (TB) Diagnostics Market Size and Forecast by Region
1.6.1 Global Tuberculosis (TB) Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Tuberculosis (TB) Diagnostics Market Size by Region, (2020-2031)
1.6.3 North America Tuberculosis (TB) Diagnostics Market Size and Prospect (2020-2031)
1.6.4 Europe Tuberculosis (TB) Diagnostics Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size and Prospect (2020-2031)
1.6.6 South America Tuberculosis (TB) Diagnostics Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Danaher
2.1.1 Danaher Details
2.1.2 Danaher Major Business
2.1.3 Danaher Tuberculosis (TB) Diagnostics Product and Solutions
2.1.4 Danaher Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Danaher Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Tuberculosis (TB) Diagnostics Product and Solutions
2.2.4 Roche Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Roche Recent Developments and Future Plans
2.3 Thermo Fisher Scientific
2.3.1 Thermo Fisher Scientific Details
2.3.2 Thermo Fisher Scientific Major Business
2.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product and Solutions
2.3.4 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.4 BD
2.4.1 BD Details
2.4.2 BD Major Business
2.4.3 BD Tuberculosis (TB) Diagnostics Product and Solutions
2.4.4 BD Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 BD Recent Developments and Future Plans
2.5 Abbott
2.5.1 Abbott Details
2.5.2 Abbott Major Business
2.5.3 Abbott Tuberculosis (TB) Diagnostics Product and Solutions
2.5.4 Abbott Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Abbott Recent Developments and Future Plans
2.6 Hologic
2.6.1 Hologic Details
2.6.2 Hologic Major Business
2.6.3 Hologic Tuberculosis (TB) Diagnostics Product and Solutions
2.6.4 Hologic Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Hologic Recent Developments and Future Plans
2.7 Qiagen
2.7.1 Qiagen Details
2.7.2 Qiagen Major Business
2.7.3 Qiagen Tuberculosis (TB) Diagnostics Product and Solutions
2.7.4 Qiagen Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Qiagen Recent Developments and Future Plans
2.8 BioMerieux
2.8.1 BioMerieux Details
2.8.2 BioMerieux Major Business
2.8.3 BioMerieux Tuberculosis (TB) Diagnostics Product and Solutions
2.8.4 BioMerieux Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 BioMerieux Recent Developments and Future Plans
2.9 Hain Lifescience
2.9.1 Hain Lifescience Details
2.9.2 Hain Lifescience Major Business
2.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Product and Solutions
2.9.4 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Hain Lifescience Recent Developments and Future Plans
2.10 Oxford Immunotec
2.10.1 Oxford Immunotec Details
2.10.2 Oxford Immunotec Major Business
2.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Product and Solutions
2.10.4 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Oxford Immunotec Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Tuberculosis (TB) Diagnostics Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Tuberculosis (TB) Diagnostics by Company Revenue
3.2.2 Top 3 Tuberculosis (TB) Diagnostics Players Market Share in 2024
3.2.3 Top 6 Tuberculosis (TB) Diagnostics Players Market Share in 2024
3.3 Tuberculosis (TB) Diagnostics Market: Overall Company Footprint Analysis
3.3.1 Tuberculosis (TB) Diagnostics Market: Region Footprint
3.3.2 Tuberculosis (TB) Diagnostics Market: Company Product Type Footprint
3.3.3 Tuberculosis (TB) Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Tuberculosis (TB) Diagnostics Consumption Value and Market Share by Type (2020-2025)
4.2 Global Tuberculosis (TB) Diagnostics Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Tuberculosis (TB) Diagnostics Consumption Value Market Share by Application (2020-2025)
5.2 Global Tuberculosis (TB) Diagnostics Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Tuberculosis (TB) Diagnostics Consumption Value by Type (2020-2031)
6.2 North America Tuberculosis (TB) Diagnostics Market Size by Application (2020-2031)
6.3 North America Tuberculosis (TB) Diagnostics Market Size by Country
6.3.1 North America Tuberculosis (TB) Diagnostics Consumption Value by Country (2020-2031)
6.3.2 United States Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
6.3.3 Canada Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
6.3.4 Mexico Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Tuberculosis (TB) Diagnostics Consumption Value by Type (2020-2031)
7.2 Europe Tuberculosis (TB) Diagnostics Consumption Value by Application (2020-2031)
7.3 Europe Tuberculosis (TB) Diagnostics Market Size by Country
7.3.1 Europe Tuberculosis (TB) Diagnostics Consumption Value by Country (2020-2031)
7.3.2 Germany Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
7.3.3 France Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
7.3.5 Russia Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
7.3.6 Italy Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Region
8.3.1 Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Region (2020-2031)
8.3.2 China Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
8.3.3 Japan Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
8.3.4 South Korea Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
8.3.5 India Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
8.3.7 Australia Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Tuberculosis (TB) Diagnostics Consumption Value by Type (2020-2031)
9.2 South America Tuberculosis (TB) Diagnostics Consumption Value by Application (2020-2031)
9.3 South America Tuberculosis (TB) Diagnostics Market Size by Country
9.3.1 South America Tuberculosis (TB) Diagnostics Consumption Value by Country (2020-2031)
9.3.2 Brazil Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
9.3.3 Argentina Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country
10.3.1 Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Country (2020-2031)
10.3.2 Turkey Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
10.3.4 UAE Tuberculosis (TB) Diagnostics Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Tuberculosis (TB) Diagnostics Market Drivers
11.2 Tuberculosis (TB) Diagnostics Market Restraints
11.3 Tuberculosis (TB) Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Tuberculosis (TB) Diagnostics Industry Chain
12.2 Tuberculosis (TB) Diagnostics Upstream Analysis
12.3 Tuberculosis (TB) Diagnostics Midstream Analysis
12.4 Tuberculosis (TB) Diagnostics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Tuberculosis (TB) Diagnostics Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Tuberculosis (TB) Diagnostics Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Tuberculosis (TB) Diagnostics Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Tuberculosis (TB) Diagnostics Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Danaher Company Information, Head Office, and Major Competitors
Table 6. Danaher Major Business
Table 7. Danaher Tuberculosis (TB) Diagnostics Product and Solutions
Table 8. Danaher Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Danaher Recent Developments and Future Plans
Table 10. Roche Company Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche Tuberculosis (TB) Diagnostics Product and Solutions
Table 13. Roche Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Roche Recent Developments and Future Plans
Table 15. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 16. Thermo Fisher Scientific Major Business
Table 17. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product and Solutions
Table 18. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. BD Company Information, Head Office, and Major Competitors
Table 20. BD Major Business
Table 21. BD Tuberculosis (TB) Diagnostics Product and Solutions
Table 22. BD Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. BD Recent Developments and Future Plans
Table 24. Abbott Company Information, Head Office, and Major Competitors
Table 25. Abbott Major Business
Table 26. Abbott Tuberculosis (TB) Diagnostics Product and Solutions
Table 27. Abbott Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Abbott Recent Developments and Future Plans
Table 29. Hologic Company Information, Head Office, and Major Competitors
Table 30. Hologic Major Business
Table 31. Hologic Tuberculosis (TB) Diagnostics Product and Solutions
Table 32. Hologic Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Hologic Recent Developments and Future Plans
Table 34. Qiagen Company Information, Head Office, and Major Competitors
Table 35. Qiagen Major Business
Table 36. Qiagen Tuberculosis (TB) Diagnostics Product and Solutions
Table 37. Qiagen Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Qiagen Recent Developments and Future Plans
Table 39. BioMerieux Company Information, Head Office, and Major Competitors
Table 40. BioMerieux Major Business
Table 41. BioMerieux Tuberculosis (TB) Diagnostics Product and Solutions
Table 42. BioMerieux Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. BioMerieux Recent Developments and Future Plans
Table 44. Hain Lifescience Company Information, Head Office, and Major Competitors
Table 45. Hain Lifescience Major Business
Table 46. Hain Lifescience Tuberculosis (TB) Diagnostics Product and Solutions
Table 47. Hain Lifescience Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Hain Lifescience Recent Developments and Future Plans
Table 49. Oxford Immunotec Company Information, Head Office, and Major Competitors
Table 50. Oxford Immunotec Major Business
Table 51. Oxford Immunotec Tuberculosis (TB) Diagnostics Product and Solutions
Table 52. Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Oxford Immunotec Recent Developments and Future Plans
Table 54. Global Tuberculosis (TB) Diagnostics Revenue (USD Million) by Players (2020-2025)
Table 55. Global Tuberculosis (TB) Diagnostics Revenue Share by Players (2020-2025)
Table 56. Breakdown of Tuberculosis (TB) Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 57. Market Position of Players in Tuberculosis (TB) Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 58. Head Office of Key Tuberculosis (TB) Diagnostics Players
Table 59. Tuberculosis (TB) Diagnostics Market: Company Product Type Footprint
Table 60. Tuberculosis (TB) Diagnostics Market: Company Product Application Footprint
Table 61. Tuberculosis (TB) Diagnostics New Market Entrants and Barriers to Market Entry
Table 62. Tuberculosis (TB) Diagnostics Mergers, Acquisition, Agreements, and Collaborations
Table 63. Global Tuberculosis (TB) Diagnostics Consumption Value (USD Million) by Type (2020-2025)
Table 64. Global Tuberculosis (TB) Diagnostics Consumption Value Share by Type (2020-2025)
Table 65. Global Tuberculosis (TB) Diagnostics Consumption Value Forecast by Type (2026-2031)
Table 66. Global Tuberculosis (TB) Diagnostics Consumption Value by Application (2020-2025)
Table 67. Global Tuberculosis (TB) Diagnostics Consumption Value Forecast by Application (2026-2031)
Table 68. North America Tuberculosis (TB) Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 69. North America Tuberculosis (TB) Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 70. North America Tuberculosis (TB) Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 71. North America Tuberculosis (TB) Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 72. North America Tuberculosis (TB) Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 73. North America Tuberculosis (TB) Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 74. Europe Tuberculosis (TB) Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 75. Europe Tuberculosis (TB) Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 76. Europe Tuberculosis (TB) Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 77. Europe Tuberculosis (TB) Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 78. Europe Tuberculosis (TB) Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 79. Europe Tuberculosis (TB) Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 80. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 81. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 82. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 83. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 84. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Region (2020-2025) & (USD Million)
Table 85. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Region (2026-2031) & (USD Million)
Table 86. South America Tuberculosis (TB) Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 87. South America Tuberculosis (TB) Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 88. South America Tuberculosis (TB) Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 89. South America Tuberculosis (TB) Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 90. South America Tuberculosis (TB) Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 91. South America Tuberculosis (TB) Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 92. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 93. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 94. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 95. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 96. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 97. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 98. Global Key Players of Tuberculosis (TB) Diagnostics Upstream (Raw Materials)
Table 99. Global Tuberculosis (TB) Diagnostics Typical Customers
Table 1. Global Tuberculosis (TB) Diagnostics Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Tuberculosis (TB) Diagnostics Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Tuberculosis (TB) Diagnostics Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Tuberculosis (TB) Diagnostics Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Danaher Company Information, Head Office, and Major Competitors
Table 6. Danaher Major Business
Table 7. Danaher Tuberculosis (TB) Diagnostics Product and Solutions
Table 8. Danaher Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Danaher Recent Developments and Future Plans
Table 10. Roche Company Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche Tuberculosis (TB) Diagnostics Product and Solutions
Table 13. Roche Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Roche Recent Developments and Future Plans
Table 15. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 16. Thermo Fisher Scientific Major Business
Table 17. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product and Solutions
Table 18. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. BD Company Information, Head Office, and Major Competitors
Table 20. BD Major Business
Table 21. BD Tuberculosis (TB) Diagnostics Product and Solutions
Table 22. BD Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. BD Recent Developments and Future Plans
Table 24. Abbott Company Information, Head Office, and Major Competitors
Table 25. Abbott Major Business
Table 26. Abbott Tuberculosis (TB) Diagnostics Product and Solutions
Table 27. Abbott Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Abbott Recent Developments and Future Plans
Table 29. Hologic Company Information, Head Office, and Major Competitors
Table 30. Hologic Major Business
Table 31. Hologic Tuberculosis (TB) Diagnostics Product and Solutions
Table 32. Hologic Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Hologic Recent Developments and Future Plans
Table 34. Qiagen Company Information, Head Office, and Major Competitors
Table 35. Qiagen Major Business
Table 36. Qiagen Tuberculosis (TB) Diagnostics Product and Solutions
Table 37. Qiagen Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Qiagen Recent Developments and Future Plans
Table 39. BioMerieux Company Information, Head Office, and Major Competitors
Table 40. BioMerieux Major Business
Table 41. BioMerieux Tuberculosis (TB) Diagnostics Product and Solutions
Table 42. BioMerieux Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. BioMerieux Recent Developments and Future Plans
Table 44. Hain Lifescience Company Information, Head Office, and Major Competitors
Table 45. Hain Lifescience Major Business
Table 46. Hain Lifescience Tuberculosis (TB) Diagnostics Product and Solutions
Table 47. Hain Lifescience Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Hain Lifescience Recent Developments and Future Plans
Table 49. Oxford Immunotec Company Information, Head Office, and Major Competitors
Table 50. Oxford Immunotec Major Business
Table 51. Oxford Immunotec Tuberculosis (TB) Diagnostics Product and Solutions
Table 52. Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Oxford Immunotec Recent Developments and Future Plans
Table 54. Global Tuberculosis (TB) Diagnostics Revenue (USD Million) by Players (2020-2025)
Table 55. Global Tuberculosis (TB) Diagnostics Revenue Share by Players (2020-2025)
Table 56. Breakdown of Tuberculosis (TB) Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 57. Market Position of Players in Tuberculosis (TB) Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 58. Head Office of Key Tuberculosis (TB) Diagnostics Players
Table 59. Tuberculosis (TB) Diagnostics Market: Company Product Type Footprint
Table 60. Tuberculosis (TB) Diagnostics Market: Company Product Application Footprint
Table 61. Tuberculosis (TB) Diagnostics New Market Entrants and Barriers to Market Entry
Table 62. Tuberculosis (TB) Diagnostics Mergers, Acquisition, Agreements, and Collaborations
Table 63. Global Tuberculosis (TB) Diagnostics Consumption Value (USD Million) by Type (2020-2025)
Table 64. Global Tuberculosis (TB) Diagnostics Consumption Value Share by Type (2020-2025)
Table 65. Global Tuberculosis (TB) Diagnostics Consumption Value Forecast by Type (2026-2031)
Table 66. Global Tuberculosis (TB) Diagnostics Consumption Value by Application (2020-2025)
Table 67. Global Tuberculosis (TB) Diagnostics Consumption Value Forecast by Application (2026-2031)
Table 68. North America Tuberculosis (TB) Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 69. North America Tuberculosis (TB) Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 70. North America Tuberculosis (TB) Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 71. North America Tuberculosis (TB) Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 72. North America Tuberculosis (TB) Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 73. North America Tuberculosis (TB) Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 74. Europe Tuberculosis (TB) Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 75. Europe Tuberculosis (TB) Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 76. Europe Tuberculosis (TB) Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 77. Europe Tuberculosis (TB) Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 78. Europe Tuberculosis (TB) Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 79. Europe Tuberculosis (TB) Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 80. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 81. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 82. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 83. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 84. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Region (2020-2025) & (USD Million)
Table 85. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value by Region (2026-2031) & (USD Million)
Table 86. South America Tuberculosis (TB) Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 87. South America Tuberculosis (TB) Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 88. South America Tuberculosis (TB) Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 89. South America Tuberculosis (TB) Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 90. South America Tuberculosis (TB) Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 91. South America Tuberculosis (TB) Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 92. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Type (2020-2025) & (USD Million)
Table 93. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Type (2026-2031) & (USD Million)
Table 94. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Application (2020-2025) & (USD Million)
Table 95. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Application (2026-2031) & (USD Million)
Table 96. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Country (2020-2025) & (USD Million)
Table 97. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value by Country (2026-2031) & (USD Million)
Table 98. Global Key Players of Tuberculosis (TB) Diagnostics Upstream (Raw Materials)
Table 99. Global Tuberculosis (TB) Diagnostics Typical Customers
LIST OF FIGURES
Figure 1. Tuberculosis (TB) Diagnostics Picture
Figure 2. Global Tuberculosis (TB) Diagnostics Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Tuberculosis (TB) Diagnostics Consumption Value Market Share by Type in 2024
Figure 4. Culture-Based Diagnostics
Figure 5. Sputum Smear Microscopy
Figure 6. Rapid Molecular Diagnostics
Figure 7. Others
Figure 8. Global Tuberculosis (TB) Diagnostics Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Tuberculosis (TB) Diagnostics Consumption Value Market Share by Application in 2024
Figure 10. Diagnostic Laboratories Picture
Figure 11. Hospitals Picture
Figure 12. Global Tuberculosis (TB) Diagnostics Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global Tuberculosis (TB) Diagnostics Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 14. Global Market Tuberculosis (TB) Diagnostics Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 15. Global Tuberculosis (TB) Diagnostics Consumption Value Market Share by Region (2020-2031)
Figure 16. Global Tuberculosis (TB) Diagnostics Consumption Value Market Share by Region in 2024
Figure 17. North America Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 18. Europe Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 19. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 20. South America Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 21. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 22. Company Three Recent Developments and Future Plans
Figure 23. Global Tuberculosis (TB) Diagnostics Revenue Share by Players in 2024
Figure 24. Tuberculosis (TB) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 25. Market Share of Tuberculosis (TB) Diagnostics by Player Revenue in 2024
Figure 26. Top 3 Tuberculosis (TB) Diagnostics Players Market Share in 2024
Figure 27. Top 6 Tuberculosis (TB) Diagnostics Players Market Share in 2024
Figure 28. Global Tuberculosis (TB) Diagnostics Consumption Value Share by Type (2020-2025)
Figure 29. Global Tuberculosis (TB) Diagnostics Market Share Forecast by Type (2026-2031)
Figure 30. Global Tuberculosis (TB) Diagnostics Consumption Value Share by Application (2020-2025)
Figure 31. Global Tuberculosis (TB) Diagnostics Market Share Forecast by Application (2026-2031)
Figure 32. North America Tuberculosis (TB) Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 33. North America Tuberculosis (TB) Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 34. North America Tuberculosis (TB) Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 35. United States Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 36. Canada Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 37. Mexico Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 38. Europe Tuberculosis (TB) Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 39. Europe Tuberculosis (TB) Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 40. Europe Tuberculosis (TB) Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 41. Germany Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 42. France Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 43. United Kingdom Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 44. Russia Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 45. Italy Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 46. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 47. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 48. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value Market Share by Region (2020-2031)
Figure 49. China Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 50. Japan Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 51. South Korea Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 52. India Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 53. Southeast Asia Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 54. Australia Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 55. South America Tuberculosis (TB) Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 56. South America Tuberculosis (TB) Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 57. South America Tuberculosis (TB) Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 58. Brazil Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 59. Argentina Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 60. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 61. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 62. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 63. Turkey Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 64. Saudi Arabia Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 65. UAE Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 66. Tuberculosis (TB) Diagnostics Market Drivers
Figure 67. Tuberculosis (TB) Diagnostics Market Restraints
Figure 68. Tuberculosis (TB) Diagnostics Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Tuberculosis (TB) Diagnostics Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. Tuberculosis (TB) Diagnostics Picture
Figure 2. Global Tuberculosis (TB) Diagnostics Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Tuberculosis (TB) Diagnostics Consumption Value Market Share by Type in 2024
Figure 4. Culture-Based Diagnostics
Figure 5. Sputum Smear Microscopy
Figure 6. Rapid Molecular Diagnostics
Figure 7. Others
Figure 8. Global Tuberculosis (TB) Diagnostics Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Tuberculosis (TB) Diagnostics Consumption Value Market Share by Application in 2024
Figure 10. Diagnostic Laboratories Picture
Figure 11. Hospitals Picture
Figure 12. Global Tuberculosis (TB) Diagnostics Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global Tuberculosis (TB) Diagnostics Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 14. Global Market Tuberculosis (TB) Diagnostics Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 15. Global Tuberculosis (TB) Diagnostics Consumption Value Market Share by Region (2020-2031)
Figure 16. Global Tuberculosis (TB) Diagnostics Consumption Value Market Share by Region in 2024
Figure 17. North America Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 18. Europe Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 19. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 20. South America Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 21. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 22. Company Three Recent Developments and Future Plans
Figure 23. Global Tuberculosis (TB) Diagnostics Revenue Share by Players in 2024
Figure 24. Tuberculosis (TB) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 25. Market Share of Tuberculosis (TB) Diagnostics by Player Revenue in 2024
Figure 26. Top 3 Tuberculosis (TB) Diagnostics Players Market Share in 2024
Figure 27. Top 6 Tuberculosis (TB) Diagnostics Players Market Share in 2024
Figure 28. Global Tuberculosis (TB) Diagnostics Consumption Value Share by Type (2020-2025)
Figure 29. Global Tuberculosis (TB) Diagnostics Market Share Forecast by Type (2026-2031)
Figure 30. Global Tuberculosis (TB) Diagnostics Consumption Value Share by Application (2020-2025)
Figure 31. Global Tuberculosis (TB) Diagnostics Market Share Forecast by Application (2026-2031)
Figure 32. North America Tuberculosis (TB) Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 33. North America Tuberculosis (TB) Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 34. North America Tuberculosis (TB) Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 35. United States Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 36. Canada Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 37. Mexico Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 38. Europe Tuberculosis (TB) Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 39. Europe Tuberculosis (TB) Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 40. Europe Tuberculosis (TB) Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 41. Germany Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 42. France Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 43. United Kingdom Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 44. Russia Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 45. Italy Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 46. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 47. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 48. Asia-Pacific Tuberculosis (TB) Diagnostics Consumption Value Market Share by Region (2020-2031)
Figure 49. China Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 50. Japan Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 51. South Korea Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 52. India Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 53. Southeast Asia Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 54. Australia Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 55. South America Tuberculosis (TB) Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 56. South America Tuberculosis (TB) Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 57. South America Tuberculosis (TB) Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 58. Brazil Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 59. Argentina Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 60. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value Market Share by Type (2020-2031)
Figure 61. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value Market Share by Application (2020-2031)
Figure 62. Middle East & Africa Tuberculosis (TB) Diagnostics Consumption Value Market Share by Country (2020-2031)
Figure 63. Turkey Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 64. Saudi Arabia Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 65. UAE Tuberculosis (TB) Diagnostics Consumption Value (2020-2031) & (USD Million)
Figure 66. Tuberculosis (TB) Diagnostics Market Drivers
Figure 67. Tuberculosis (TB) Diagnostics Market Restraints
Figure 68. Tuberculosis (TB) Diagnostics Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Tuberculosis (TB) Diagnostics Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
